ANA News
2019-01-28 – Major NIH-funded clinical trial adds nuanced evidence linking brain and vascular health. Learn more here: Does intensive blood pressure control reduce dementia?
2019-01-25 – A groundbreaking new study in mice and people, conducted by ANA President Dr. David Holtzman and his research team at Washington University School of Medicine in St. Louis, found that sleep deprivation increases levels of the key Alzheimer’s protein tau. And, in follow-up studies in the mice, the…
2019-01-18 – NIH-funded study sheds new light on brain circuits related to affective and social dysfunction. Learn more here: New Findings Reveal Surprising Role of the Cerebellum in Reward and Social Behaviors
2019-01-17 – The Traumatic Brain Injury Program Reauthorization Act of 2018, which extends the federal Traumatic Brain Injury Program through 2024, was signed into law on December 21, 2018. View full bill here: Traumatic Brain Injury Program Reauthorization Act of 2018
2019-01-17 – At the ANA’s 143rd annual meeting in Atlanta, Georgia, Anli Liu, MD sat down with NeurlogyLive to discuss how she and colleagues developed a proof-of-concept trial with patients using the NeuroPace Responsive Neurostimulator (RNS). Check out her interview here: Anli Liu, MD: Responsive…
2019-01-16 – Impaired slow-wave sleep and more tau protein may be linked to early AD, study finds. Learn more: Bad Sleep and More Tau: Tied to Early Alzheimer's?
2019-01-11 – A resource with information on gene regulation from more than 2,000 human brains yielded insights into mental disorders and will enable future studies of human brain development and function. Learn more: Revealing gene regulation in the brain
2019-01-10 – Read ANA member Dr. S. Andrew Josephson's take on the fascinating case about a man in Nebraska who was on the brink of death and came back from dangerous brain swelling in Live Science: How Did 'Miracle' Man Come Back from Dangerous Brain Swelling?
2019-01-09 – In a study of fruit flies, NIH scientists suggested that the body’s immune system may play a critical role in the damage caused by aging brain disorders. The results are based on experiments in which the researchers altered the activity of Cdk5, a gene that preclinical studies have suggested is…
2019-01-08 – A new publication from ANA president David Holtzman, MD summarizes increases in our understanding of the involvement of TREM2 and microglia in Alzheimer's disease development that may open new therapeutic strategies targeting the immune system to influence AD pathogenesis. Learn more: New insights…